Autor(es): Castilho, Marcelo Santos ; Guido, Rafael V. C. ; Andricopulo, Adriano D. ; Castilho, Marcelo Santos ; Guido, Rafael V. C. ; Andricopulo, Adriano D.
Data: 2014
Origem: Oasisbr
Assunto(s): QSAR; Coronary heart disease; Trifluoro-3-amino-2-propanol derivatives; CETP; Inhibitors; Coronariopatias
Texto completo: acesso restrito. p. 6242-6252
Submitted by Suelen Reis (suziy.ellen@gmail.com) on 2014-01-14T17:06:46Z No. of bitstreams: 1 1-s2.0-S0968089607005445-main.pdf: 463973 bytes, checksum: a753790176d7a99f075fe5669cc452c4 (MD5)
Approved for entry into archive by Alda Lima da Silva (sivalda@ufba.br) on 2014-01-21T20:58:37Z (GMT) No. of bitstreams: 1 1-s2.0-S0968089607005445-main.pdf: 463973 bytes, checksum: a753790176d7a99f075fe5669cc452c4 (MD5)
Made available in DSpace on 2014-01-21T20:58:37Z (GMT). No. of bitstreams: 1 1-s2.0-S0968089607005445-main.pdf: 463973 bytes, checksum: a753790176d7a99f075fe5669cc452c4 (MD5) Previous issue date: 2007
Coronary heart disease (CHD) is one of the major causes of human death. The most successful therapeutic approach available is based on the reduction of low density-lipoprotein cholesterol (LDL-C). However, it is believed that the next paradigm in CHD treatment will rely on increased HDL-C levels. One of the most promising strategies for this goal is the inhibition of cholesteryl ester transfer protein (CETP). In the present work, robust classical 2D QSAR (r2 = 0.76, q2 = 0.72) and hologram QSAR (r2 = 0.88, q2 = 0.70) models were developed for a series of 85 CETP inhibitors (N-N-disubstituted trifluoro-3-amino-2-propanol derivatives). These models are complementary in nature and highlight important structural features for the design of novel CETP inhibitors with improved potency.
